GliaPharm SA

Skyvor Medical develops a cutting-edge digital health platform to expedite clinical research. Our Advanced Trial Operation Management (ATOM) System enables modern, patient-centric clinical trials, by seamlessly integration of EDC, eCOA, ePRO and other digital solutions onto one platform.  

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.